ORITAVANCIN
- CAS No.
- 171099-57-3
- Chemical Name:
- ORITAVANCIN
- Synonyms
- Orbactiv;CS-2274;LY 333328;ORITAVANCIN;Ollivan Star;brand name: Orbactiv;Oritavancin (LY333328);Oritavancin, trifluoacetate salt;13C6]-Oritavancin, trifluoacetate salt;Oritavancin (Lyophilized Powder For IV Infusion)
- CBNumber:
- CB92451283
- Molecular Formula:
- C86H97Cl3N10O26
- Molecular Weight:
- 1793.1
- MDL Number:
- MFCD12756396
- MOL File:
- 171099-57-3.mol
- MSDS File:
- SDS
- TDS File:
- TDS
| Product description | Number | Pack Size | Price |
| Oritavancin | 461622 | 1mg | $410 |
| Oritavancin | 461622 | 2.5mg | $623 |
| Oritavancin | AA16180 | 2mg | $211.4 |
| Oritavancin | AA16180 | 5mg | $432.45 |
| Oritavancin | AA16180 | 10mg | $691.8 |
| More product size | |||
| Density | 1.59±0.1 g/cm3(Predicted) |
|---|---|
| storage temp. | Store at -20°C |
| solubility | Soluble in DMSO |
| pka | 2.93±0.70(Predicted) |
| FDA UNII | PUG62FRZ2E |
| ATC code | J01XA05 |
SAFETY
Risk and Safety Statements
| Symbol(GHS) |  GHS07 |
|---|---|
| Signal word | Warning |
| Hazard statements | H315-H319-H335 |
| Precautionary statements | P264-P280-P302+P352-P321-P332+P313-P362-P305+P351+P338-P337+P313-P261-P271-P304+P340-P312-P403+P233-P405-P501 |
ORITAVANCIN price
| Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|---|
| Usbiological | 461622 | Oritavancin | 171099-57-3 | 1mg | $410 | 2026-06-03 | Buy |
| Usbiological | 461622 | Oritavancin | 171099-57-3 | 2.5mg | $623 | 2026-06-03 | Buy |
| Biosynth | AA16180 | Oritavancin | 171099-57-3 | 2mg | $211.4 | 2026-06-04 | Buy |
| Biosynth | AA16180 | Oritavancin | 171099-57-3 | 5mg | $432.45 | 2026-06-04 | Buy |
| Biosynth | AA16180 | Oritavancin | 171099-57-3 | 10mg | $691.8 | 2026-06-04 | Buy |
ORITAVANCIN Chemical Properties,Uses,Production
Definition
ChEBI: A semisynthetic glycopeptide used (as its bisphosphate salt) for the treatment of acute bacterial skin and skin structure infections caused or suspected to be caused by susceptible isolates of designated Gram-positive microorganisms including MRSA.
Clinical Use
Antibacterial agent
Enzyme inhibitor
This novel, semi-synthetic glycopeptide antibiotic (FW = 1793.10 g/mol; CAS 171099-57-3), also known as LY333328, Orbactiv, and (4R)-22-O- (3-amino-2,3,6-trideoxy-3-C-methyl-a-L-arabinohexopyranosyl)-N3-(p-(pchlorophenyl) benzyl)vancomycin, disrupts the cell membrane of Grampositive bacteria and inhibits both transglycosylation and transpeptidation. Oritavancin differs from vancomycin by the presence of a hydrophobic N-4-(4-chlorophenyl)benzyl substituent on the disaccharide, the addition of a 4-epi-vancosamine monosaccharide to the amino acid residue in Ring-6, and replacement of the vancosamine moiety by 4-epi-vancosamine. When compared vancomycin, teicoplanin, and quinupristin-dalfopristin (Synercid) against 219 strains of enterococci and staphylococci, including vancomycin-resistant enterococci and methicillinresistant methicillinresistant Staphylococcus aureus, LY333328 demonstrated superior activity against vancomycin-resistant enterococci and was the only antibiotic which was bactericidal. Indeed, a single infusion of this antibiotic (1200 mg) can clear serious bacterial skin infections, including methicillin-resistant Staphylococcus aureus, or MRSA, as effectively as the usual 7-10 day, twice-daily regimen of vancomycin now needed to treat patients.
Drug interactions
Potentially hazardous interactions with other drugs
Anticoagulants: possibly increases warfarin
concentration.
Metabolism
In vitro human liver microsome studies indicated that oritavancin is not metabolised. It is excreted unchanged; less than 1% and 5% of a dose is recovered in the urine and the faeces.
ORITAVANCIN Preparation Products And Raw materials
Raw materials
Preparation Products
| Supplier | Tel | Country | ProdList | Advantage | |
|---|---|---|---|---|---|
| Shaanxi Haibo Biotechnology Co., Ltd | +86-18629295024 | qinhe02@xaltbio.com | China | 996 | 58 |
| Hebei Zhuanglai Chemical Trading Co Ltd | +86-16264648883 | niki@zlchemi.com | China | 7240 | 58 |
| Wuhan JiyunZen Tech Co., Ltd. | +86-18062099985 | Amyjiyunzen@yeah.net | China | 672 | 58 |
| Henan Tianfu Chemical Co.,Ltd. | +86-0371-55170693 +86-19937530512 | info@tianfuchem.com | China | 21531 | 55 |
| ATK CHEMICAL COMPANY LIMITED | +undefined-21-51877795 | ivan@atkchemical.com | China | 32998 | 60 |
| career henan chemical co | +86-0371-86658258 | sales@coreychem.com | China | 29766 | 58 |
| Shanghai Worldyang Chemical Co.,Ltd. | +86-021-56795779 +86-13651600618 | sales@worldyachem.com | China | 963 | 58 |
| BOC Sciences | +1-631-485-4226 | inquiry@bocsci.com | United States | 19935 | 58 |
| Longyan Tianhua Biological Technology Co., Ltd | 0086 18039857276 18039857276 | CHINA | 2777 | 58 | |
| Qiuxian Baitai New Material Co., LTD | +86-19932103556 | sale2@hbyalin.com | China | 1645 | 58 |
Related articles
- What is Oritavancin?
- Oritavancin is a second-generation lipoglycopeptide antibiotic derived from modifications of chloroeremomycin, a naturally occ....
- Mar 10，2022
View Lastest Price from ORITAVANCIN manufacturers
| Image | Update time | Product | Price | Min. Order | Purity | Supply Ability | Manufacturer | |
|---|---|---|---|---|---|---|---|---|
 |
2026-08-08 | ORITAVANCIN
171099-57-3
|
0.99 | RongNa Biotechnology Co.,Ltd | ||||
 |
2026-04-21 | Oritavancin(LY-333328)
171099-57-3
|
$85.00-339.00 | 10g | TargetMol Chemicals Inc. | |||
 |
2026-04-10 | ORITAVANCIN
171099-57-3
|
$2.00-5.00 | 1KG | 99% hplc | 500TONS | Wuhan JiyunZen Tech Co., Ltd. |
-
- ORITAVANCIN
171099-57-3
- 0.99
- RongNa Biotechnology Co.,Ltd
-
- Oritavancin(LY-333328)
171099-57-3
- $85.00-339.00
- TargetMol Chemicals Inc.
-
- ORITAVANCIN
171099-57-3
- $2.00-5.00
- 99% hplc
- Wuhan JiyunZen Tech Co., Ltd.
